The market for clinical trial planning and design services is


London, December 15, 2021 (GLOBE NEWSWIRE) – Root analysis announced the addition of the report “Clinical Trial Planning and Clinical Trial Design Services Market, 2021-2030” to its offerings list.

The failure of a clinical trial can impose a huge financial burden on sponsors, estimated at between $ 800 million and $ 1.4 billion. It is further believed that a considerable part of the losses can be avoided by efficient test planning. In other words, effective trial planning and design plays a critical role in enabling accurate, safe and rapid study execution at all sites.

To order this 190-plus-page report, which contains over 80 figures and over 90 tables, please visit this page https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market.html

Key market information

Over 130 players claim to offer clinical trial planning and design services
This segment of the service industry is dominated by start-ups / small businesses (2-50 employees) and medium-sized players (51-200 employees), which represent more than 63% of the contemporary landscape. In addition, the majority (over 60%) of stakeholders are based in North America.

Almost all of the players claim to offer study design / protocol development services
On the other hand, almost 55% of service providers report having the capabilities to provide sample size and power analysis services. In addition, about 50% of clinical trial planning and design service providers provide statistical analysis and planning services.

Since 2016, more than 45+ partnerships have been signed by service providers
Interestingly, the maximum number of partnership agreements was signed in 2020, the majority of which were acquisitions (43%), followed by clinical trial design agreements (18%). It should be noted that partnering activity in this area has increased at a CAGR of 40%, over the past five years.

More than 20 mergers and acquisitions were carried out in this field, during the period 2016-2020
It was observed that the majority of transactions were intracontinental (79%), involving participants from different countries. Expansion of the service portfolio and geographic consolidation were also seen as key value drivers of the acquisition activity, followed by geographic expansion (24%) and consolidation of the service portfolio (13% ).

North America and Europe are expected to capture 69% of the shares (in terms of service revenues) of the market, in 2030

The Asia-Pacific clinical trial planning and design services market is expected to grow at a relatively faster rate (10.7%), followed by the rest of the world market (9.5%). At present, almost 63% of total revenues are generated by projects involving a statistical analysis plan, eCRF and site identification and selection; this trend is unlikely to change significantly in the short to medium term.

To request a copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market.html

Answers to key questions

  • Who are the main players involved in providing clinical trial planning and design services around the world?
  • What are the regulatory guidelines established in different geographies and their requirements related to the planning and design of clinical trials?
  • What types of partnership models are most commonly adopted by stakeholders engaged in this industry?
  • What are the main value drivers of M&A activity observed in this area?
  • How are current and future market opportunities likely to be distributed among key market segments?
  • What are the anticipated future trends related to clinical trial planning and design services?

The financial opportunity in the Clinical Trial Planning and Design Services Market has been analyzed in the following segments:

Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Therapeutic areas

  • Oncological disorders
  • Cardiovascular disorders
  • Inflammatory disorders
  • Neurological disorders

Test phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

Type of service

  • Statistical analysis plan
  • eCRF
  • Site identification and selection
  • Medical writing
  • Others

The research includes detailed profiles of major service providers (listed below) engaged in this field; each profile presents an overview of the company, information related to its clinical trial planning and service portfolio focused on design, recent developments and enlightened outlook for the future.

  • PharmaLex
  • Emergo
  • Cytel
  • Health Policy Assistant
  • Biosciences CD
  • LLX Solutions
  • GV
  • ADM Korea
  • ClinAsia
  • BioPoint

For more details, please visit
https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market.html or email [email protected]

You may also be interested in the following titles:

  1. Site Management Organizations Market, 2021-2035
  2. Virtual Clinical Trial Service Provider Market, 2020-2050
  3. AI-Based Clinical Trial Solution Provider Market, 2020-2030
  4. Patient Recruitment and Retention Services Market (2nd Edition), 2021-2030


Source link

Previous After hazing-related suspensions, Wall's school board approves hiring of substitutes, interim athletic director
Next How writing methods have evolved over time